Collins Helen Louise
Kura Oncology, Inc. · Director
Collins Helen Louise is listed in public filings as director. This Collins Helen Louise insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Kura Oncology, Inc. (KURA), Enliven Therapeutics, Inc. (ELVN), and IO Biotech, Inc. (IOBT). Investors use Collins Helen Louise's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $117k2.4k shares | SellApr 17, 2026 | $48.06 | -- | |
| $115k2.4k shares | SellApr 17, 2026 | $47.39 | -- | |
| $6.4k140 shares | SellApr 17, 2026 | $45.81 | -- | |
| $1.4M40k shares | SellMar 25, 2026 | $35.10 | -- | |
| $139k5k shares | SellMar 17, 2026 | $27.76 | -- | |
| $306k10.1k shares | SellMar 10, 2026 | $30.19 | -- | |
| $897k29.9k shares | SellMar 9, 2026 | $30.02 | -- | |
| $1.2M45k shares | SellFeb 17, 2026 | $26.17 | -- | |
| $24k816 shares | SellOct 18, 2024 | $30.00 | -- |